Biotech

Companies & Industries News

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 09.02.2022.

#medicalnews
#COVID19
#biotech
#pharma
#PharmaScrip

Companies And Industries

@eduardoarmienta shared
On Feb 8, 2022
RT @CellBiology_LR: Using Natural Sugars to Label & Trace Stem Cells | “It’s extraordinary to find, 30 years after starting my research in the field of labeling cells, that...there may be better, easier ways to track these cells in the brain,” said Jeff Bulte, Ph.D. https://t.co/wU5exLEfCe https://t.co/ArNM1FezKz
Open
Using Natural Sugars to Label & Trace Stem Cells

Using Natural Sugars to Label & Trace Stem Cells

The ability to see things in living tissues has always been challenging for researchers. When scientists are studying cells, the various parts of the cell, | Cell And Molecular Biology

@biospace shared
On Feb 9, 2022
Montreal-based biotech snags $50M to build team of #biotech #medicalnews https://t.co/zTFT4Jro4s
Open
Montreal-based Biotech Snags $50M to Build Team of "Drug Hunters"

Montreal-based Biotech Snags $50M to Build Team of "Drug Hunters"

The new funds will go toward advancing Congruence’s Revenir™ platform, a computational tool that models diseases that come from cellular proteins misfolding in order to understand them ...

@BioWorld shared
On Feb 8, 2022
Money raised by biopharma through early February: 2022 vs. 2021 vs. 2020 vs. 2019 https://t.co/Fk5tGKfOt3 https://t.co/NeVb32TJH5
Open
Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

Money raised by biopharma: 2022 vs. 2021 vs. 2020 vs. 2019

Total raised in public, private and other financings of biopharma companies, comparing 2022 vs. 2021 vs. 2020 vs. 2019.

@pharmaphorum shared
On Feb 9, 2022
Revenue from #COVID19 antibody Xevudy and vaccine adjuvants bolstered @GSK's Q4 revenues, offsetting a decline in top-selling shingles vaccine Shingrix #pharma https://t.co/b0jQFhIGk3
Open
GSK gets £1.4bn sales lift from COVID-19 products in 2021

GSK gets £1.4bn sales lift from COVID-19 products in 2021

Revenue from COVID-19 antibody Xevudy and vaccine adjuvants bolstered GSK's Q4 revenues, offsetting a decline in top-selling shingles vaccine Shingrix

@PharmaScrip shared
On Feb 3, 2022
Slowing COVID-19 Sales Will Drag On Roche In 2022 https://t.co/LDDn2abvDp #PharmaScrip
Open
Slowing COVID-19 Sales Will Drag On Roche In 2022

Slowing COVID-19 Sales Will Drag On Roche In 2022

<p>Strong sales of COVID-19 diagnostics and therapies helped the Swiss company ride out the biosimilar attack in 2021, but it will not have the same buffer this year.</p> <p>&nbsp;</p>

@biospace shared
On Feb 8, 2022
Companies making the biggest bucks from COVID-19 therapeutics sales #covid19 #medicalnews https://t.co/5J5UwrPbmg
Open
Companies Making the Biggest Bucks from COVID-19 Therapeutics Sales

Companies Making the Biggest Bucks from COVID-19 Therapeutics Sales

Here’s a look at five companies that produced non-vaccine treatments for COVID-19.

@matthewherper shared
On Feb 7, 2022
STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel https://t.co/sw7t7RdaqJ
Open
STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

STAT to launch inaugural STATUS List, with leaders and influencers selected by expert panel

@FierceBiotech shared
On Feb 7, 2022
Editas terminates Chief Medical Officer effective immediately https://t.co/tgQxzbWWEQ
Open
Editas suddenly terminates Chief Medical Officer Lisa Michaels without explanation

Editas suddenly terminates Chief Medical Officer Lisa Michaels without explanation

Editas Medicine has fired Chief Medical Officer Lisa Michaels, M.D., just 15 months into her tenure at the gene editing company.